Concepts (142)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Crohn Disease | 7 | 2022 | 808 | 0.610 |
Why?
|
| Inflammatory Bowel Diseases | 6 | 2022 | 646 | 0.500 |
Why?
|
| Gastrointestinal Diseases | 2 | 2003 | 149 | 0.330 |
Why?
|
| Child | 15 | 2022 | 7355 | 0.230 |
Why?
|
| Nutritional Status | 2 | 2003 | 79 | 0.220 |
Why?
|
| Colitis, Ulcerative | 3 | 2022 | 800 | 0.210 |
Why?
|
| Body Height | 2 | 2022 | 107 | 0.200 |
Why?
|
| Growth | 1 | 2003 | 42 | 0.190 |
Why?
|
| Child Nutrition Disorders | 1 | 2003 | 13 | 0.190 |
Why?
|
| Health Services | 1 | 2003 | 56 | 0.190 |
Why?
|
| Human Growth Hormone | 1 | 2022 | 51 | 0.180 |
Why?
|
| Gastroenterology | 1 | 2003 | 157 | 0.160 |
Why?
|
| Growth Disorders | 1 | 2020 | 66 | 0.160 |
Why?
|
| Adolescent | 12 | 2022 | 9606 | 0.160 |
Why?
|
| Severity of Illness Index | 4 | 2019 | 1917 | 0.160 |
Why?
|
| Eosinophilia | 1 | 2001 | 87 | 0.160 |
Why?
|
| Abdominal Pain | 1 | 2001 | 143 | 0.150 |
Why?
|
| Child Development | 1 | 2021 | 166 | 0.150 |
Why?
|
| Sex Characteristics | 1 | 2021 | 333 | 0.140 |
Why?
|
| Patient Care | 1 | 2019 | 97 | 0.140 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2019 | 111 | 0.140 |
Why?
|
| Immunologic Factors | 1 | 2019 | 176 | 0.130 |
Why?
|
| Child, Preschool | 6 | 2021 | 3829 | 0.130 |
Why?
|
| Phenobarbital | 1 | 1997 | 33 | 0.130 |
Why?
|
| Sex Factors | 1 | 2020 | 1105 | 0.130 |
Why?
|
| Vomiting | 1 | 1997 | 108 | 0.130 |
Why?
|
| Adenoma, Liver Cell | 1 | 1996 | 3 | 0.130 |
Why?
|
| Periodicity | 1 | 1997 | 113 | 0.120 |
Why?
|
| Bone Density | 1 | 1998 | 237 | 0.120 |
Why?
|
| Hypnotics and Sedatives | 1 | 1997 | 137 | 0.120 |
Why?
|
| Milk Proteins | 1 | 2016 | 24 | 0.120 |
Why?
|
| Infant Formula | 1 | 2016 | 18 | 0.120 |
Why?
|
| Milk Hypersensitivity | 1 | 2016 | 12 | 0.120 |
Why?
|
| Celiac Disease | 1 | 2019 | 219 | 0.120 |
Why?
|
| Mass Screening | 1 | 2020 | 696 | 0.120 |
Why?
|
| Problem Solving | 1 | 2015 | 55 | 0.110 |
Why?
|
| Gastritis | 1 | 2015 | 37 | 0.110 |
Why?
|
| Fever | 1 | 2015 | 122 | 0.110 |
Why?
|
| Medication Adherence | 1 | 2015 | 122 | 0.110 |
Why?
|
| Bacterial Infections | 1 | 2015 | 179 | 0.100 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2019 | 624 | 0.100 |
Why?
|
| Infant, Premature | 1 | 2016 | 297 | 0.100 |
Why?
|
| Chronic Disease | 3 | 2019 | 960 | 0.100 |
Why?
|
| Longitudinal Studies | 3 | 2022 | 1161 | 0.100 |
Why?
|
| Female | 14 | 2022 | 48702 | 0.100 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2015 | 242 | 0.100 |
Why?
|
| Inflammation | 1 | 2019 | 1050 | 0.100 |
Why?
|
| Antibodies, Monoclonal | 3 | 2019 | 1395 | 0.090 |
Why?
|
| Blood Sedimentation | 1 | 2012 | 13 | 0.090 |
Why?
|
| Menarche | 2 | 2022 | 30 | 0.090 |
Why?
|
| Thalidomide | 1 | 2012 | 55 | 0.090 |
Why?
|
| Male | 13 | 2022 | 44557 | 0.090 |
Why?
|
| Fistula | 1 | 2012 | 42 | 0.090 |
Why?
|
| Prospective Studies | 4 | 2022 | 4560 | 0.090 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2012 | 353 | 0.090 |
Why?
|
| Prednisone | 1 | 2012 | 242 | 0.090 |
Why?
|
| Hermanski-Pudlak Syndrome | 1 | 2010 | 1 | 0.080 |
Why?
|
| Humans | 19 | 2022 | 93515 | 0.080 |
Why?
|
| Liver Neoplasms | 1 | 1996 | 776 | 0.080 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2019 | 2465 | 0.080 |
Why?
|
| Intestines | 1 | 2012 | 432 | 0.070 |
Why?
|
| Colitis | 1 | 2010 | 261 | 0.070 |
Why?
|
| Follow-Up Studies | 3 | 2019 | 3830 | 0.060 |
Why?
|
| Quality of Life | 1 | 2015 | 1780 | 0.060 |
Why?
|
| Hospitalization | 1 | 2012 | 937 | 0.060 |
Why?
|
| Infant | 2 | 2016 | 3220 | 0.050 |
Why?
|
| Anthropometry | 1 | 2003 | 75 | 0.050 |
Why?
|
| Treatment Outcome | 5 | 2015 | 9099 | 0.050 |
Why?
|
| Biopsy | 2 | 2015 | 1175 | 0.050 |
Why?
|
| Interleukin-8 | 1 | 2022 | 88 | 0.050 |
Why?
|
| Growth Hormone | 1 | 2022 | 97 | 0.050 |
Why?
|
| Interleukin-1beta | 1 | 2022 | 88 | 0.040 |
Why?
|
| Thioguanine | 1 | 2001 | 17 | 0.040 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2022 | 116 | 0.040 |
Why?
|
| Mercaptopurine | 1 | 2001 | 53 | 0.040 |
Why?
|
| Age Determination by Skeleton | 1 | 2020 | 12 | 0.040 |
Why?
|
| Infant, Newborn | 2 | 2016 | 2479 | 0.040 |
Why?
|
| Puberty, Delayed | 1 | 2020 | 18 | 0.040 |
Why?
|
| Interleukin-6 | 1 | 2022 | 276 | 0.040 |
Why?
|
| Infliximab | 2 | 2012 | 162 | 0.040 |
Why?
|
| Interferon-gamma | 1 | 2022 | 460 | 0.040 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2001 | 244 | 0.040 |
Why?
|
| Jews | 1 | 2019 | 42 | 0.040 |
Why?
|
| Intraepithelial Lymphocytes | 1 | 2019 | 18 | 0.040 |
Why?
|
| Medical History Taking | 1 | 2019 | 82 | 0.040 |
Why?
|
| Butyrophilins | 1 | 2019 | 28 | 0.040 |
Why?
|
| Immunosuppressive Agents | 2 | 2015 | 990 | 0.040 |
Why?
|
| Diet, Gluten-Free | 1 | 2019 | 60 | 0.040 |
Why?
|
| Child Nutritional Physiological Phenomena | 1 | 1998 | 11 | 0.040 |
Why?
|
| Age of Onset | 1 | 2019 | 342 | 0.030 |
Why?
|
| Radius | 1 | 1998 | 30 | 0.030 |
Why?
|
| Glutens | 1 | 2019 | 85 | 0.030 |
Why?
|
| Puberty | 1 | 1998 | 54 | 0.030 |
Why?
|
| Antigens | 1 | 2019 | 224 | 0.030 |
Why?
|
| Hormones | 1 | 1998 | 136 | 0.030 |
Why?
|
| Pedigree | 1 | 2019 | 961 | 0.030 |
Why?
|
| Reference Values | 1 | 1998 | 608 | 0.030 |
Why?
|
| Migraine Disorders | 1 | 1997 | 41 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2019 | 696 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2019 | 424 | 0.030 |
Why?
|
| Liver | 2 | 2001 | 1210 | 0.030 |
Why?
|
| Protein Hydrolysates | 1 | 2016 | 9 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2015 | 2585 | 0.030 |
Why?
|
| Milk | 1 | 2016 | 56 | 0.030 |
Why?
|
| Parenteral Nutrition | 1 | 2016 | 64 | 0.030 |
Why?
|
| Birth Weight | 1 | 2016 | 150 | 0.030 |
Why?
|
| Enteral Nutrition | 1 | 2016 | 104 | 0.030 |
Why?
|
| Cattle | 1 | 2016 | 397 | 0.030 |
Why?
|
| Prevalence | 1 | 2019 | 1321 | 0.030 |
Why?
|
| Amino Acids | 1 | 2016 | 249 | 0.030 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2016 | 82 | 0.030 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2015 | 160 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2015 | 657 | 0.030 |
Why?
|
| Recurrence | 1 | 1997 | 1190 | 0.030 |
Why?
|
| Intestinal Mucosa | 1 | 2019 | 824 | 0.030 |
Why?
|
| Gastrointestinal Agents | 1 | 2015 | 181 | 0.020 |
Why?
|
| Calcium | 1 | 1998 | 1176 | 0.020 |
Why?
|
| Retrospective Studies | 3 | 2016 | 10164 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2016 | 1546 | 0.020 |
Why?
|
| Hypersensitivity, Immediate | 1 | 2012 | 64 | 0.020 |
Why?
|
| Prognosis | 1 | 2019 | 3911 | 0.020 |
Why?
|
| Adalimumab | 1 | 2012 | 92 | 0.020 |
Why?
|
| Constriction, Pathologic | 1 | 2012 | 207 | 0.020 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2012 | 91 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2015 | 836 | 0.020 |
Why?
|
| Risk Factors | 1 | 2019 | 5899 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2015 | 2802 | 0.020 |
Why?
|
| Disease Progression | 1 | 2012 | 1531 | 0.020 |
Why?
|
| Young Adult | 1 | 2019 | 6930 | 0.020 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2012 | 1001 | 0.010 |
Why?
|
| Adult | 2 | 2019 | 27918 | 0.010 |
Why?
|
| Leukopenia | 1 | 2001 | 64 | 0.010 |
Why?
|
| Leukocyte Count | 1 | 2001 | 210 | 0.010 |
Why?
|
| Mice, Inbred C3H | 1 | 2002 | 369 | 0.010 |
Why?
|
| Azathioprine | 1 | 2001 | 122 | 0.010 |
Why?
|
| Animals | 2 | 2016 | 28155 | 0.010 |
Why?
|
| Erythrocytes | 1 | 2001 | 239 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2001 | 711 | 0.010 |
Why?
|
| Middle Aged | 1 | 2019 | 27573 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2001 | 1847 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2002 | 2495 | 0.010 |
Why?
|
| Mice | 1 | 2002 | 12269 | 0.000 |
Why?
|